Sponsors / DWTX
DWTX

Dogwood Therapeutics Inc.

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
1Trials in this database
4Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainNCT06848348DWTXPhase 2Active not recruiting2026-12Estimated

Latest recorded trial changes

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

NCT06848348 · Dogwood Therapeutics Inc.

· 2 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Compare wording
− Before

Measure: To explore the efficacy of Halneuron in the treatment of patients with Chemotherapy-Induced Neuropathic Pain Measure: To explore the Safety of Halneuron in the treatment of patients with Chemotherapy-Induced Neuropathic Pain

+ After

Measure: NRS Pain Measure: Safety Assessments

Planned enrollment increased by 40 participants

− Before

200 participants (planned)

+ After

240 participants (planned)

Check registry source